New study tests best way to use firsekibart to stop gout attacks
NCT ID NCT07616531
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether taking Firsekibart regularly (every 4 weeks) is better than using it only when a gout flare starts. It involves 118 adults who had no flares during 24 weeks of initial treatment. The goal is to see which approach prevents more gout attacks over the next 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Firsekibart (a drug injected under the skin)
- What this could lead to
- If successful, this could show that taking Firsekibart on a regular schedule is better than waiting for a flare to use it, helping prevent gout attacks.
- What could go wrong
- This is a small, early-stage trial with only 118 participants, so results may not apply to everyone. The drug may cause side effects, and the study is not yet recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GOUTY ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Changxin People's Hospital
Huzhou, China
-
Fuzhou University Affiliated Provincial Hospital
Fuzhou, China
-
Jinhua Municipal Central Hospital
Jinhua, China
-
Ningbo Medical Center Lihuili Hospital
Ningbo, China
-
The First People's Hospital of Wenlin
Wenzhou, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, China
-
The Second Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China
-
Tongde Hospital of Zhejiang Province
Hangzhou, China
-
Zhejiang Hospital
Hangzhou, China
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.